237 related articles for article (PubMed ID: 27245919)
1. Low BDNF is associated with cognitive impairments in patients with Parkinson's disease.
Wang Y; Liu H; Zhang BS; Soares JC; Zhang XY
Parkinsonism Relat Disord; 2016 Aug; 29():66-71. PubMed ID: 27245919
[TBL] [Abstract][Full Text] [Related]
2. Burnout and cognitive impairment: Associated with serum BDNF in a Chinese Han population.
He SC; Zhang YY; Zhan JY; Wang C; Du XD; Yin GZ; Cao B; Ning YP; Soares JC; Zhang XY
Psychoneuroendocrinology; 2017 Mar; 77():236-243. PubMed ID: 28119229
[TBL] [Abstract][Full Text] [Related]
3. Association of low serum BDNF with depression in patients with Parkinson's disease.
Wang Y; Liu H; Du XD; Zhang Y; Yin G; Zhang BS; Soares JC; Zhang XY
Parkinsonism Relat Disord; 2017 Aug; 41():73-78. PubMed ID: 28576603
[TBL] [Abstract][Full Text] [Related]
4. Altered BDNF levels are associated with cognitive impairment in Parkinson's disease patients with depression.
Wang Y; Bai LP; Liu W; Zhu XD; Zhang XY
Parkinsonism Relat Disord; 2022 Oct; 103():122-128. PubMed ID: 36108429
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
[TBL] [Abstract][Full Text] [Related]
6. Relationship of circulatory BDNF with cognitive deficits in people with Parkinson's disease.
Khalil H; Alomari MA; Khabour OF; Al-Hieshan A; Bajwa JA
J Neurol Sci; 2016 Mar; 362():217-20. PubMed ID: 26944151
[TBL] [Abstract][Full Text] [Related]
7. Increased BDNF may not be associated with cognitive impairment in heroin-dependent patients.
Luan X; Tao J; Zhang J; Xie Y; Zhang X; Su H; He J
Medicine (Baltimore); 2017 Apr; 96(15):e6582. PubMed ID: 28403087
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment and BDNF serum levels.
Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
[TBL] [Abstract][Full Text] [Related]
9. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
[TBL] [Abstract][Full Text] [Related]
10. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J
J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836
[TBL] [Abstract][Full Text] [Related]
11. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
[TBL] [Abstract][Full Text] [Related]
12. Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor.
Huang Y; Yun W; Zhang M; Luo W; Zhou X
J Int Med Res; 2018 Apr; 46(4):1477-1485. PubMed ID: 29350074
[TBL] [Abstract][Full Text] [Related]
13. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in association of cognition with BDNF in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
16. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
Galtier I; Nieto A; Lorenzo JN; Barroso J
J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
[TBL] [Abstract][Full Text] [Related]
18. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.
Zhen YF; Zhang J; Liu XY; Fang H; Tian LB; Zhou DH; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2013 May; 227(1):93-100. PubMed ID: 23263460
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).
Rosa RF; Ugolini-Lopes MR; Gandara APR; Vendramini MBG; Campanholo KR; Dutra L; de Andrade DCO
Rheumatology (Oxford); 2021 Jan; 60(1):179-187. PubMed ID: 32613245
[TBL] [Abstract][Full Text] [Related]
20. Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis.
Jiang L; Zhang H; Wang C; Ming F; Shi X; Yang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():168-174. PubMed ID: 30017781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
